Medicover Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

John Stubbington

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	0.5%
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	10.3yrs

Recente managementupdates

Recent updates

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 28

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Apr 14

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Mar 21

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Feb 09 Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16

CEO

John Stubbington (56 yo)

no data

Tenure

Mr. John Stubbington serves as Member of the Supervisory Board of Dom Lekarski S.A. since 2021. Mr. Stubbington served as Chief Operating Officer of Healthcare Services of Medicover AB (publ) until May 01,...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Fredrik Rågmark	Executive Officer	no data	€3.31m	1.12% SEK 420.8m
John Stubbington	Chief Executive Officer	no data	geen gegevens	0.53% SEK 198.3m
Anand Patel	Chief Financial Officer	less than a year	geen gegevens	0.0021% SEK 772.2k
Jaroslaw Urbanczyk	Chief Information Officer	5.6yrs	geen gegevens	0.010% SEK 3.9m
Hanna Bjellquist	Head of Investor Relations	no data	geen gegevens	geen gegevens
Jenny Brandt	General Legal Counsel	no data	geen gegevens	0.040% SEK 15.0m
Andrew Vallance-Owen	Chief Marketing Officer	no data	geen gegevens	geen gegevens
Kamila Skorupinski	Chief People Officer	1.1yrs	geen gegevens	geen gegevens
Staffan Ternstrom	Chief Operating Officer for Diagnostic Services	3.9yrs	geen gegevens	0.099% SEK 37.4m

0.8yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MCOV B wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Robert Jochnick	Honorary Board Member	no data	geen gegevens	1.2% SEK 452.7m
Fredrik Stenmo	Independent Chairman	20.3yrs	€131.10k	4.38% SEK 1.7b
Margareta Nordenvall	Independent Director	24.3yrs	€68.90k	0.060% SEK 22.5m
Arno Bohn	Independent Director	24.3yrs	€65.80k	0.20% SEK 74.8m
Cecil Michael Flemming	Independent Director	10.3yrs	€81.50k	geen gegevens
Anne Berner	Independent Director	3.1yrs	€62.80k	geen gegevens
Azita Shariati	Independent Director	3.1yrs	€65.80k	0.0015% SEK 550.0k
Peder Jochnick	Independent Director	13.3yrs	€56.80k	2.57% SEK 969.2m
Sonali Chandmal	Independent Director	8.3yrs	€78.90k	0.017% SEK 6.2m
Claudia Olsson	Director	less than a year	geen gegevens	geen gegevens

10.3yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MCOV B zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.3 jaar).

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/05/19 22:12
Aandelenkoers aan het einde van de dag	2025/05/19 00:00
Inkomsten	2025/03/31
Jaarlijkse inkomsten	2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Medicover AB (publ) wordt gevolgd door 9 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
null null	ABG Sundal Collier
null null	ABG Sundal Collier Sponsored
Kristofer Liljeberg-Svensson	Carnegie Investment Bank AB

Medicover Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Honorary Board Member recently sold kr1.2m worth of stock

Insufficient new directors

Medicover AB (Publ) Approves Board Elections

Medicover AB (Publ) Announces CEO Changes, Effective 1 May 2025

Insider recently bought kr498k worth of stock

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Recent updates

Honorary Board Member recently sold kr1.2m worth of stock

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Consensus EPS estimates increase by 10%

Insufficient new directors

Medicover AB (Publ) Approves Board Elections

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Upcoming dividend of €0.15 per share

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Medicover AB (publ) (OM:MCOV B) acquired Cityfit Sp Z O O in a transaction valued at approximately PLN 570 million.

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Medicover AB (publ) Proposes Dividend for 2024, Payable on 9 May 2025

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Dividend of €0.15 announced

Medicover AB (Publ) Proposes Dividend for 2024

Medicover AB (Publ) Announces CEO Changes, Effective 1 May 2025

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Consensus EPS estimates fall by 65%

Insider recently bought kr498k worth of stock

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Third quarter 2024 earnings released: €0.029 loss per share (vs €0.007 loss in 3Q 2023)

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Second quarter 2024 earnings released: EPS: €0.042 (vs €0.037 in 2Q 2023)

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

General Legal Counsel recently sold kr1.2m worth of stock

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023)

Upcoming dividend of €0.12 per share

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

New minor risk - Earnings quality

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Dividend of €0.12 announced

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Full year 2023 earnings: EPS exceeds analyst expectations

Now 24% undervalued

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Consensus EPS estimates increase by 27%

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Independent Chairman recently bought kr3.9m worth of stock

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

New minor risk - Earnings quality

Third quarter 2023 earnings released

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Independent Director recently bought kr303k worth of stock

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Independent Director recently bought kr1.4m worth of stock

Independent Chairman recently bought kr6.3m worth of stock

Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022)

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Chief Information Officer recently bought kr321k worth of stock

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

Consensus EPS estimates fall by 10%

Now 21% undervalued after recent price drop

Upcoming dividend of €0.12 per share at 0.7% yield

Full year 2022 earnings: Revenues in line with analyst expectations